Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer with actionable genetic alterations. This is an ASCO Meeting Abstract from the 2023 ASCO ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

A new test developed by scientists in the United Kingdom could provide urinary tract infection (UTI) patients with quicker ...

Expansion of genetic testing to the general population is one of the ambitions of the UK Government's 2025 10-year Health Plan for England, as part of a strategy for transition from “sickness to ...

Antimicrobial Susceptibility Testing Market in North America: “North America occupied about 40% of the market share in 2020 and the region is offering significant growth opportunities for market ...

The field of antimicrobial susceptibility testing (AST) and resistance detection is rapidly evolving to address the global threat posed by antimicrobial resistance. In recent years, a ...

The global issue of antimicrobial resistance has been called a “slow motion catastrophe” resulting from the excessive and often inappropriate use of antibiotics to fight bacterial infections. 1 A long ...

LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global antimicrobial susceptibility testing market (AST) forecasts the market to witness a CAGR of over 5% during the forecast ...

In recent years, many efforts have been undertaken to establish new methods for DST to be used on a routine level. The epidemiology of drug-resistant and MDR-TB has posed an enormous need for faster ...